when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

910 stories

Jun 15, 26Elicio’s KRAS cancer vaccine fails in Phase 2, shares plummetendpoints

Jun 15, 26STAT+: A key European clinical trial registry lacks complete and timely results, an analysis findsstat

Jun 15, 26Medicare drug price rule may target under-the-skin Keytruda and Opdivobiopharma dive

Jun 15, 26Lilly scores early positive data for new JAK drugbiopharma dive

Jun 15, 26J&J multiple myeloma drug gains edge in earlier stage diseasebiopharma dive

Jun 15, 26STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and morestat

Jun 15, 26Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutendpoints

Jun 15, 26STAT+: One California politician’s unexpected crusade against ultra-processed foodstat

Jun 13, 26Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73stat

Jun 12, 26Merck brings Welireg-Keytruda combo to treat kidney cancerendpoints

Jun 12, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Jun 12, 26STAT+: Prometheus raises $12 billion in capital for artificial engineersstat

Jun 12, 26STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and morestat

Jun 12, 26Chile offers new data on food warning label efficacystat

Jun 12, 26Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rulestat

Jun 11, 26Drinking during pregnancy rose after 2020, new CDC data suggeststat

Jun 11, 26Nonprofit buys experimental cancer drug to maintain patient accessstat

Jun 11, 26Study highlights influence of socioeconomic status on children’s brain developmentstat

Jun 11, 26STAT+: Abridge inks deals with Nvidia and Lillystat

Jun 11, 26Summit pulls $500M share sale a day after announcing itbiopharma dive

Jun 11, 26J&J looks to widen Imaavy’s use; $300M backs rare disease drug launchbiopharma dive

Jun 11, 26STAT+: Enliven Therapeutics’ leukemia drug shows promise in new studystat

Jun 11, 26STAT+: ‘Synthetic lethality’ could trigger another round of biotech M&Astat

Jun 11, 26HHS responds coolly to paper on alcohol riskstat

Jun 11, 26Opinion: We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850stat

Jun 10, 26Parabilis sets a record with a $670M biotech IPObiopharma dive

Jun 10, 26STAT+: Hope for Kendall Square’s lab marketstat

Jun 10, 26Parabilis' $670M IPO sets new biotech record, will fund cancer drugendpoints

Jun 9, 26STAT+: Trump’s health care affordability czar takes aim at hospitalsstat

Jun 9, 26FDA OKs first new sunscreen ingredient in more than 25 yearsstat

← prevpage 17 of 31next →